CLDX
Celldex Therapeutics Inc.
Latest News for CLDX
Celldex Therapeutics ($CLDX) announced an update on their ongoing clinical study. Study Overview: Celldex Therapeutics is launching a Phase 1 study......
Mizuho Securities analyst reiterated a Buy rating on Celldex today and set a price target of $48.00. Currently, the analyst consensus on Celldex is......
In a report released today, Etzer Darout from Barclays maintained a Sell rating on Celldex, with a price target of $24.00. According to TipRanks, D......
Celldex Therapeutics ($CLDX) announced an update on their ongoing clinical study. Study Overview Celldex Therapeutics (CLDX) is running a late-stag......
News data is sourced from MarketXLS API and updated regularly.
Showing 4 of 4 articles.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | CLDX | $25.17 | +2.1% | 809.22K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Celldex Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW